NOVITRON INTERNATIONAL INC
SC 13G/A, 1996-11-12
LABORATORY ANALYTICAL INSTRUMENTS
Previous: CYPRESS BIOSCIENCE INC, S-3/A, 1996-11-12
Next: CONVERSE INC, 10-Q, 1996-11-12



United States
Securities and Exchange Commission
Washington, D.C.  20549


SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 2)


Name of Issuer:                              Novitron International, Inc.
Title of Class of Securities:             Common Stock
CUSIP Number:                              670088103





CUSIP No. 670088103                                           Page 2 of 4 Pages

1. Name of Reporting Person                Alphi Investment Management Company
                                                            IRS No. 36-3588013

2. Check the appropriate box if a member of a group     (a) [ ]      (b) [ ]

3. SEC Use Only

4. Citizenship or Place of Organization                       Illinois

5. Sole Voting Power             Not applicable - see Item 4

6. Shared Voting Power           Not applicable - see Item 4

7. Sole Dispositive Power        Not applicable - see Item 4

8. Shared Dispositive Power      Not applicable - see Item 4

9. Aggregate Amount Beneficially Owned by Each Reporting Person      
                                 Not applicable - see Item 4

10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares [ ]

11. Percent of Class Represented by Amount in Row 9      
                                 Not applicable - see Item 4

12. Type of Reporting Person                       IA









CUSIP No. 670088103                               Page 3 of 4 Pages


Item 1(a).  Name of Issuer

     This Amendment No. 2 to the Schedule 13G relates to the Shares of 
Common Stock of Novitron International, Inc.  (the "Shares" and the 
"Company" respectively).

Item 1(b).  Address of Issuer's Principal Executive Offices

     The executive offices of the Company are located at One Gateway Center,
Suite 411, Newton, MA  02158.

Item 2(a).  Name of Person Filing

     This Amendment No. 2 to the Schedule 13G is being filed on behalf 
of Alphi Investment Management Company ("AIMCO"), an Illinois corporation.

Item 2(b).  Address of Principal Business Office

     The principal business offices of AIMCO are located at 
155 Pfingsten Road, Suite 360, Deerfield, IL  60015.

Item 2(c).  Citizenship

     U.S.A.

Item 2(d).  Title of Class of Securities

     Common Stock

Item 2(e).  CUSIP Number

      670088103

Item 3.  Type of Person

     Investment Adviser registered under Section 203 of the 
Investment Advisers Act of 1940.


Item 4.  Ownership          Not applicable

Item 5.  Ownership of Five Percent or less of a Class:   
This statement is being filed to report the fact that as of 
October 31, 1996 AIMCO has ceased to be the beneficial owner 
of more than five percent of the class of securities.  [x]

Item 6.  Ownership of More than Five Percent on Behalf of Another Person
     Not applicable

Item 7.	Identification and Classification of the Subsidiary Which Acquired 
the Security Being Reported on By the Parent Holding Company	
     Not applicable.

Item 8.  Identification and Classification of Members of the Group	
     Not applicable.

Item 9.  Notice of Dissolution of Group		
     Not applicable.

Item 10.  Certification

     By signing below, I certify that, to the best of my knowledge 
and belief, the securities referred to above were acquired in the 
ordinary course of business and were not acquired for the purpose 
of and do not have the effect of changing or influencing the control 
of the issuer of such securities and were not acquired in connection 
with or as a participant in any transaction having such purpose 
or effect.

SIGNATURE

     After reasonable inquiry and to the best of my knowledge and 
belief, I certify that the information set forth in this statement 
is true, complete and correct.

November  8, 1996
Date
Philip R. Smith                                                  
Signature
Philip R. Smith   /   Secretary
Name/Title



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission